Bristol-Myers Squibb Co. (BMY)

Income Statement

Difficulty: Beginner

The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Bristol-Myers Squibb Co., Consolidated Income Statement

USD $ in millions

	12 months ended	Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014		Dec 31, 2013
	Net product sales
	Alliance and other revenues
	Revenues
	Cost of products sold
	Gross margin
	Marketing, selling and administrative
	Research and development
	Operating income
	Interest expense
	Interest income
	Provision for restructuring
	Litigation and other settlements
	Equity in net income of affiliates
	Divestiture gains
	Royalties and licensing income
	Transition and other service fees
	Other alliance and licensing income
	Pension charges
	Intangible asset impairment
	Equity investment impairment
	Written option adjustment
	Loss on debt redemption
	Other
	Other income (expense), net
	Earnings before income taxes
	Provision for income taxes
	Net earnings
	Noncontrolling interest
	Net earnings attributable to BMS

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

Item	Description	The company
Revenues	Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.	Bristol-Myers Squibb Co.’s revenues increased from 2015 to 2016 and from 2016 to 2017.
Operating income	The net result for the period of deducting operating expenses from operating revenues.	Bristol-Myers Squibb Co.’s operating income increased from 2015 to 2016 but then slightly declined from 2016 to 2017.
Earnings before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Bristol-Myers Squibb Co.’s earnings before income taxes increased from 2015 to 2016 but then slightly declined from 2016 to 2017.
Net earnings attributable to BMS	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Bristol-Myers Squibb Co.’s net earnings attributable to BMS increased from 2015 to 2016 but then declined significantly from 2016 to 2017.

	Bristol-Myers Squibb Co.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality